CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...